Current breakthroughs in real-time glucose tracking devices for diabetes

Padmavathi Sanagarapu

Sanagarapu Padmavathi Priyadarshini Institute of Pharmaceutical Education and Research, 5th Mile, Pulladigunta, Guntur-522017, Andhra Pradesh, India

Abstract

The pharmaceutical industry is undergoing a significant transformation driven by the integration of digital technologies, collectively known as Industry 4.0. This shift is redefining how drugs are developed, manufactured, and distributed. Key technologies such as the Internet of Things (IoT), Artificial Intelligence (AI), and big data analytics are at the forefront of this change, enabling smart manufacturing, real-time process optimization, and enhanced supply chain management. IoT facilitates the creation of interconnected production environments where sensors and devices continuously monitor critical parameters, ensuring optimal conditions and predictive maintenance. AI accelerates drug discovery through predictive modeling, automates quality control processes, and employs predictive analytics to enhance maintenance and process improvement. Big data empowers data-driven decision-making, ensures regulatory compliance through comprehensive analysis, and supports the shift toward personalized medicine by enabling customized drug production. Despite the significant benefits, the adoption of these technologies poses challenges, including integration with existing systems, data security concerns, and navigating a complex regulatory landscape. This review explores these technologies' impact on pharmaceutical manufacturing, highlighting successful case studies and best practices. Additionally, it discusses the future directions, including the move towards fully autonomous systems and the importance of collaboration between tech companies, manufacturers, and regulators to drive innovation and ensure compliance. The continued evolution of digital technologies in pharma manufacturing promises to enhance efficiency, reduce costs, and deliver more personalized treatments.

Keywords: CGM, Sensors, Technology, Glucose, Wearable, Dexcom

References

1. Clarke SF, Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. British journal of biomedical science. 2012 Jan 1;69(2):83-93. https://doi.org/10.1080/09674845.2012.12002443
2. Ajjan RA, Cummings MH, Jennings P, Leelarathna L, Rayman G, Wilmot EG. Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: implications for clinical practice. Diabetes and Vascular Disease Research. 2018 May;15(3):175-84.
https://doi.org/10.1177/1479164118756240
3. Baumstark A, Schmid C, Pleus S, Rittmeyer D, Haug C, Freckmann G. Accuracy assessment of an advanced blood glucose monitoring system for self-testing with three reagent system lots following ISO 15197: 2013. Journal of Diabetes Science and Technology. 2014 Nov;8(6):1241-2.
https://doi.org/10.1177/1932296814546529
4. Zisser HC, Bailey TS, Schwartz S, Ratner RE, Wise J. Accuracy of the SEVEN® continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements. Journal of Diabetes Science and Technology. 2009 Sep;3(5):1146-54.
https://doi.org/10.1177/193229680900300519
5. Shukla, S. K., Govender, P. P., & Tiwari, A. (2016). Polymeric micellar structures for biosensor technology. In Advances in biomembranes and lipid self-assembly (Vol. 24, pp. 143-161). Academic Press.
https://doi.org/10.1016/bs.abl.2016.04.005
6. Benjamin EM. Self-monitoring of blood glucose: the basics. Clinical diabetes. 2002 Jan 1;20(1):45-7.
https://doi.org/10.2337/diaclin.20.1.45
7. Gifford R. Continuous glucose monitoring: 40 Years, what we′ ve learned and what’s next. ChemPhysChem. 2013 Jul 22;14(10):2032-44.
https://doi.org/10.1002/cphc.201300172
8. Bailey TS, Ahmann A, Brazg R, Christiansen M, Garg S, Watkins E, Welsh JB, Lee SW. Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor. Diabetes technology & therapeutics. 2014 May 1;16(5):277-83.
https://doi.org/10.1089/dia.2013.0222
9. McGarraugh G, Brazg R, Weinstein R. FreeStyle Navigator Continuous Glucose Monitoring System with TRUstart algorithm, a 1-hour warm-up time. Journal of Diabetes Science and Technology. 2011 Jan;5(1):99-106.
https://doi.org/10.1177/193229681100500114
10. Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014 Oct 1;37(10):2702-9.
https://doi.org/10.2337/dc14-0303
11. Bequette BW. Continuous glucose monitoring: real-time algorithms for calibration, filtering, and alarms. Journal of diabetes science and technology. 2010 Mar;4(2):404-18.
https://doi.org/10.1177/193229681000400222
12. Klonoff AN, Lee WA, Xu NY, Nguyen KT, DuBord A, Kerr D. Six digital health technologies that will transform diabetes. Journal of diabetes science and technology. 2023 Jan;17(1):23949.
https://doi.org/10.1177/19322968211043498
13. Davidson PC, Hebblewhite HR, Steed RD, Bode BW. Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocrine Practice. 2008 Dec 1;14(9):1095-101.
https://doi.org/10.4158/EP.14.9.1095
14. Smart CE, King BR, McElduff P, Collins CE. In children using intensive insulin therapy, a 20‐g variation in carbohydrate amount significantly impacts on postprandial glycaemia. Diabetic Medicine. 2012 Jul;29(7):e21-4.
https://doi.org/10.1111/j.1464-5491.2012.03595.x
15. Pańkowska E, Ładyżyński P, Foltyński P, Mazurczak K. A randomized controlled study of an insulin dosing application that uses recognition and meal bolus estimations. Journal of diabetes science and technology. 2017 Jan;11(1):43-9.
https://doi.org/10.1177/1932296816683409
16. Kovatchev BP, Breton M, Dalla Man C, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes.
https://doi.org/10.1177/193229680900300106
17. Diabetes Research in Children Network (DirecNet) Study Group. Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real‐time continuous glucose monitor (the FreeStyle Navigator). Pediatric diabetes. 2008 Apr;9(2):142-7.
https://doi.org/10.1111/j.1399-5448.2007.00301.x
18. O'Connor PJ, Sperl‐Hillen JM, Fazio CJ, Averbeck BM, Rank BH, Margolis KL. Outpatient diabetes clinical decision support: current status and future directions. Diabetic Medicine. 2016 Jun;33(6):734-41.
https://doi.org/10.1111/dme.13090
19. Jia P, Zhao P, Chen J, Zhang M. Evaluation of clinical decision support systems for diabetes care: an overview of current evidence. Journal of evaluation in clinical practice. 2019 Feb;25(1):66-77.
https://doi.org/10.1111/jep.12968
20. Zhong A, Choudhary P, McMahon C, Agrawal P, Welsh JB, Cordero TL, Kaufman FR. Effectiveness of automated insulin management features of the MiniMed® 640G sensor-augmented insulin pump. Diabetes technology & therapeutics. 2016 Oct 1;18(10):657-63.
https://doi.org/10.1089/dia.2016.0216
21. DeBoer MD, Cherñavvsky DR, Topchyan K, Kovatchev BP, Francis GL, Breton MD. Heart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D. Pediatric diabetes. 2017 Nov;18(7):540-6.
https://doi.org/10.1111/pedi.12454s
22. Avinash M, Suryaprabha M, Sreekanth N, Dineshreddy B, Baburao CH. Advanced and Recent Emerging Trends in Insulin Drug Delivery Systems. International Journal of Bio-Pharma Research. 2012;1.